PRODUCTS & INNOVATION
Quality medicines are just the start when looking to grow in developing countries.
May 29 2018
Patients and doctors in emerging markets want more than just high-quality medicines, says Andrew Lane, executive vice president of Abbott's Established Pharmaceuticals Division (EPD) that sells branded generic drugs solely in fast-growing emerging countries. Andrew's discussion of how companies can do more appears in the publication eyeforpharma.
Abbott Reports Third-Quarter Results
Opportunity Abounds in Emerging Markets
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.